In this issue: Science News | Current Publications | Industry News | Policy News  | Events Subscribe | Unsubscribe


TOP STORIES

Study Reveals Major Genetic Differences between Blood and Tissue Cells
Important questions raised about genetic research based only on blood samples; new treatment in vascular disease foreseen at the same time. [McGill University, Montreal]

MesenCult_645x110_v03



SCIENCE NEWS

Stem Cells: Environmental Factors Instruct Lineage Choice of Blood Progenitor Cells
New bioimaging method allows researchers to prove for the first time that not only cell-intrinsic mechanisms, but also external environmental factors such as growth factors can control HPC lineage choice directly. [Helmholtz Zentrum München, Neuherberg]

Microscopic "Beads" Could Help Create "Designer" Immune Cells that Ignore Transplanted Organs
The degradable microparticles deliver the most powerful known form of HLA-G, a natural suppressor of the immune response, straight to dendritic cells, which typically show the immune system what to attack. [Medical College of Georgia, Augusta]

Portable DNA Purifier for Poor Countries
A new handheld device that extracts genetic material from blood and other bodily fluids by pumping fluid through a polymer-lined straw designed to trap DNA. [Boston University, Boston]

MethoCult_645x110_v01




CURRENT PUBLICATIONS

Human Term Placenta a New Abundant Source of Hematopoietic Cells-A Potent Alternative for Cord Blood and Bone Marrow
Cells derived from placental tissue were shown to differentiate into all blood lineages in vitro. Animal experiments further demonstrated successful engraftment of placenta-derived HSC, which reconstituted hematopoiesis in immunodeficient mice. [Exp Biol Med]

Functional Unresponsiveness and Replicative Senescence of Myeloid Leukemia Antigen-specific CD8+ T Cells after Allogeneic Stem Cell Transplantation
Circulating leukemia-specific CD8+ T cells are prominent in myeloid leukemia patients after HSCT, but such cells are largely functionally unresponsive, most likely due to replicative senescence. [Clin Cancer Res]

Surface Antigen Phenotypes of Hematopoietic Stem Cells from Embryos and Murine Embryonic Stem Cells
Unique phenotype signifies a developmentally immature population of cells with features of both primitive and mature HSC. [Blood]

Partially Matched Related Donor Transplantation Can Achieve Outcomes Comparable with Unrelated Donor Transplantation for Patients with Hematologic Malignancies
Comparisons show that every major end point, including relapse, non-relapse mortality, overall survival, and leukemia-free survival, was comparable between the partially matched related donors and the unrelated groups. [Clin Cancer Res]

Cyclin A Is Redundant in Fibroblasts but Essential in Hematopoietic and Embryonic Stem Cells
Cyclin A, the first cyclin ever cloned, is thought to be an essential component of the cell-cycle engine. Authors tested the requirement for cyclin A function using conditional knockout mice lacking both testis-specific cyclin A1 and ubiquitously expressed cyclin A2. [Cell]

A Novel Immunoregulatory Protein in Human Colostrum, Syntenin-1, for Promoting the Development of IgA-Producing Cells From Cord Blood B cells
This study demonstrated that levels of syntenin-1 in colostrum were correlated with IgA-inducing activities, and recombinant syntenin-1 could induce preferentially IgA production from naive B cells. [Int Immunol]

Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Myelodysplastic Syndrome: A Single-Center Experience
Pediatric patients with myelodysplastic syndromes were transplanted with unrelated donor umbilical cord blood and results were equivalent to published matched allogeneic bone marrow data. [J Clin Oncol]

Stroma-Free Mass Production of Clinical-Grade Red Blood Cells by Using Poloxamer 188 as an RBC Survival Enhancer
This RBC production protocol is a simple stroma- and serum-free culture method ensuring enhanced viability of terminally mature erythroid cells and can be easily applicable to mass production of clinical-grade RBCs as well as erythropoiesis research. [Transfusion]

Stemsoft




INDUSTRY NEWS

Novartis, Fate Race to Develop Stem-Cell Drug for Transplants
Two companies are racing to develop stem-cell therapies that may save the lives of thousands of people with blood cancer who need a transplant of bone marrow or umbilical-cord blood and can't find an adequate match.

Immucor Responds to FDA
Immucor Inc. has started a "Product Surveillance and Improvement Department" in response to threats from federal regulators to revoke its biologics license after discovering "deficiencies" in the company's manufacturing.

Six Researchers to Receive Prestigious Awards from the American Society of Hematology
The American Society of Hematology will honor six scientists who have made significant contributions to the understanding of hematologic diseases.




POLICY NEWS

House Approves $2.99 Billion FDA Budget
The House approved a $373 million budget increase to $2.99 billion for the Food and Drug Administration, the largest boost in the agency's history.

NIH

Notice of Intent to Publish a Request for Applications for the 2010 NIH Directors Pioneer Award Program

FDA

Information for Healthcare Professionals: Immunosuppressant Drugs: Required Labeling Changes
The U.S. Food and Drug Administration is requiring the makers of certain immunosuppressant drugs to update their labeling to reflect that immunosuppressed patients are at increased risk for opportunistic infections.

Food and Drug Administration: Blood Products Advisory Committee; Notice of Meeting

CBER

Vaccines and Related Biological Products Advisory Committee Meeting - July 23, 2009

Sponsored Workshops, Meetings & Conferences

501(k): BK090017 SoftBank II (R) Version 25

510(k): American Red Cross Control Cells 

Exceptions and Alternative Procedures Approved Under 21 CFR 640.120




Events

2nd TERMIS World Congress In Conjunction With 2009 Seoul Stem Cell Symposium
August 31-September 3, 2009
Seoul, South Korea

XXXVI Annual meeting European Society for Artificial Organs 2009
September 2-5, 2009
Compiègne, France

16th International Society of Developmental Biologists Congress
September 6-10, 2009
Edinburgh, United Kingdom

International Society for Hematology and Stem Cells 38th Annual Scientific Meeting
September 9-12, 2009
Athens, Greece

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.


Have we missed an important article or publication in Cord Blood News? Click here to submit!

 
forwardafriendicon

Learn more about Cord Blood News: Archives | Events | Update Profile | Contact Us
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada